|
CDC launches Web course on Infection Prevention in a Dialysis Setting |
CDC: The 1-hour self-guided training course features a flash-based slide presentation and audio narration. The course reviews the following topic areas: ------Infections that patients can get from dialysis ------Infection control recommendations for outpatient hemodialysis healthcare workers, and -------Educating your patients and their caregivers.
|
|
Study of childhood type 2 diabetes reports unusually high incidence. |
BBC: One in five ------ Prof Terry Wilkin, director of the EarlyBird Diabetes Research Study, said: "We were aghast at the finding that 55 of these children have shown impaired fasting glucose, suggesting that today's children, contemporary children, are really at quite substantial risk."
|
Healthy human microbiome characterized. |
EurekAlert: The human microbiome—as scientists call the communities of microorganisms that inhabit your skin, mouth, gut, and other parts of your body by the trillions—plays a fundamental role in keeping you healthy. These communities are also thought to cause disease when they're perturbed. But our microbiome's exact function, good and bad, is poorly understood. That could change.
|
Thiazolidinedione use may increase risk of macular edema. |
EurekAlert: Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year follow-up evaluations, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
|
Apramycin may be a useful antibiotic that causes little damage to hearing. |
EurekAlert: Surprisingly, they have found that apramycin, an antibiotic already used in veterinary medicine, fits this bill -- setting the stage for testing in humans. In a paper published online in the Proceedings of the National Academy of Sciences, a team from Switzerland, England and the University of Michigan show apramycin's high efficacy against bacteria, and low potential for causing hearing loss, through a broad range of tests in animals. That testing platform is now being used to evaluate other potential antibiotics that could tackle infections such as multidrug-resistant tuberculosis.
|
|
|
|
<< Start < Prev 311 312 313 314 315 316 317 318 319 320 Next > End >>
|
Page 316 of 2630 |